Company Quick10K Filing
Advantego
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-13
S-1 2018-08-02 Public Filing
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-28
10-Q 2017-06-30 Filed 2017-11-22
10-Q 2017-03-31 Filed 2017-11-21
10-K 2016-12-31 Filed 2017-10-19
10-Q 2016-09-30 Filed 2017-04-05
10-Q 2016-06-30 Filed 2016-09-07
10-Q 2016-03-31 Filed 2016-05-05
10-K 2015-12-31 Filed 2017-08-04
10-Q 2015-06-30 Filed 2015-12-01
10-Q 2015-06-30 Filed 2015-12-01
10-Q 2015-03-31 Filed 2015-12-01
10-K 2014-12-31 Filed 2017-08-03
10-Q 2014-09-30 Filed 2015-11-25
10-Q 2014-06-30 Filed 2015-11-09
10-Q 2014-03-31 Filed 2015-11-04
10-K 2013-12-31 Filed 2017-03-27
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-01
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-07-31
10-Q 2012-03-31 Filed 2012-05-11
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-12
10-K 2010-12-31 Filed 2011-04-12
10-Q 2010-09-30 Filed 2010-11-22
10-Q 2010-06-30 Filed 2010-08-20
10-Q 2010-03-31 Filed 2010-05-24
10-K 2009-12-31 Filed 2010-05-14
8-K 2020-05-20
8-K 2020-05-19
8-K 2020-03-30
8-K 2020-03-06
8-K 2020-02-28
8-K 2020-01-17
8-K 2019-12-12
8-K 2019-05-26
8-K 2019-03-14
8-K 2019-01-14
8-K 2018-12-18
8-K 2018-07-20
8-K 2018-06-11
8-K 2018-05-31
8-K 2018-03-02
8-K 2018-02-05
8-K 2018-01-31

Advantego Financials

ADGO Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-12-312015-12-312016-12-312017-03-312017-06-302017-09-302017-12-312018-12-312019-03-312019-06-30
Cash27111978399818414313046441523792423135
Accounts Receivable97810026252168
Inventory1650
PP&E3,9893,9893,9893,9803,9803,9803,9803,9803,980350350350
Assets4,7234,5664,4984,3854,2834,1034,0283,9863,997354364350464418838195546554
Accounts Payable12944448271670112
Long-Term Debt3504395
Liabilities28313014573843764034357487578569251963584926126501,6564,4454,782
Stockholders' Equity4,4404,4364,3534,3773,8993,7273,6253,5513,249-403-492-575-150-314-474-604-612-1,461-3,899-4,228
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-12-312015-12-312016-12-312017-03-312017-06-302017-09-302017-12-312018-12-312019-03-312019-06-30
Revenue000000000036821
Cost of Revenue1115
Gross Profit-36
R&D
SG&A2221691731539376876627-27160158130124348304
Tax0000000000000000
Net Income-249-79-229-237-482-189-29162-303-3,6702-165-160-130-163-600-745
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-12-312015-12-312016-12-312017-03-312017-06-302017-09-302017-12-312018-12-312019-03-312019-06-30
Cash Operating-149-146-131-413-130-64-33-316250-6-52-41-77-557-772
Cash Investing-3105263312974190100
Cash Financing0066350327-2625012112889484